4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-25-087085
Chief Financial Officer sold 96,000 shares at $0.01 ($950)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wood Gavin Chief Financial Officer | 2025-09-02 | Sale | −96,000 | $0.01 | $950 | 0 | D |
| Open-market sales · 96,000 sh · avg $0.01 · $950 | |||||||
Loading xslF345X05/tm2525128d1_4seq1.xml…